CN1222305C - Chinese medicine for treating liver-kidney insufficiency, qi and yin vacuity and its preparation method - Google Patents
Chinese medicine for treating liver-kidney insufficiency, qi and yin vacuity and its preparation method Download PDFInfo
- Publication number
- CN1222305C CN1222305C CN 03106361 CN03106361A CN1222305C CN 1222305 C CN1222305 C CN 1222305C CN 03106361 CN03106361 CN 03106361 CN 03106361 A CN03106361 A CN 03106361A CN 1222305 C CN1222305 C CN 1222305C
- Authority
- CN
- China
- Prior art keywords
- deficiency
- yin
- cortex moutan
- liver
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention discloses a new Chinese medicine for curing the deficiency of both the liver and kidney and the deficiency of both QI and YIN. The present invention takes american ginseng, prepared rehmannia root, asiatic cornelian cherry fruit, common yan rhizome, cortex moutan, oriental waterplantain rhizome and Indian bread as raw materials, various effective ingredients in the raw materials are respectively extracted according to different characteristics of the Chinese medicines, and extracts are prepared into proper medicinal preparations, such as concentration pills, tablets, capsules or oral medicinal liquid, etc. The medicine of the present invention can cure the deficiency of both the liver and kidney and the deficiency of both QI and YIN and has the effects of nourishing liver and kidney and supplementing QI and nourishing YIN.
Description
Technical field
The present invention relates to a kind of Chinese medicine for the treatment of deficiency of the liver and kindey, deficiency of qi and yin.The invention still further relates to the preparation method of this medicine.
Background technology
Chinese medicine is thought " the kidney being the origin of congenital constitution ", " root of life ".The growth of human body, growth, aging are decided by the prosperity and decline of kidney vital essence, and the maturation of men and women's reproductive function is so that decline also is the vital essence based on kidney.Kidney essense belongs to cloudy, and therefore the kidney QI belonging to YANG claims that kidney essense is a kidney yin; Kidney qi is a kidney yang.Kidney yin is the basic of the cloudy liquid of human body to the nourishing that plays a part to make moist of each internal organs organ of human body, and kidney yang plays a part warm and biochemical to each internal organs organ of human body, be human body at all.Kidney yin, existing its relative property of kidney yang have its interaction again.People's aging generally all is from kidney, is caused the decline of other internal organs by renal failure, simultaneously relative histoorgan, also certain variation will inevitably take place, as kidney governing bones, give birth to marrow, fill brain, the mountain skill is skilful, waist is a house of kidney, tooth being the surplus of the bone is had one's ideas straightened out in ear, and pupil belongs to kidney, its Hua Zaifa, therefore, suffering from a deficiency of the kidney waist soreness just occurs, dizzy forgetful, tooth takes off, and audition is become deaf, order flower turns white, corresponding aging phenomenon such as loss of hairs.In modern age, the domestic parties concerned to the theory of visceral outward manifestation of the traditional Chinese medical science " kidney ", have done deep research, think the essence of kidney, and------there is substantial connection in interrenal system and hypothalamus---hypophysis---gonad system to hypophysis except that kidney itself, with hypothalamus.Deficiency of the kidney or kidney qi be the people of decline too early, can present going down of hormonal system function, immunologic function low, and have influence on the physiological function of other internal organs, decline ahead of time appears.Test research factually, interrenal system and hypophysis---the function of gonad system increases and reduces with the age, proves the reason of human senility, and said with Chinese medicine " suffering from a deficiency of the kidney " is relevant closely." deficiency syndrome should be treated by tonifying method ", this is a basic principle.According to the spirit of the traditional Chinese medical science " treating different diseases with the same therapeutic principle ", all can take method of treatment based on the kidney invigorating.
And the concrete application of the kidney invigorating therapy also should coach according to the theory of Chinese medicine determination of treatment based on pathogenesis obtained through differentiation of symptoms and signs.In general, the syndrome of suffering from a deficiency of the kidney is mainly divided insufficiency of kidney-YANG and deficiency of the kidney yin two big classes.Yang deficiency has the deficiency of vital energy concurrently more, the deficiency of YIN damage of essence of holding concurrently more, and treatment must the empty character of difference, adopts corresponding method of treatment and square medicine.LIUWEI DIHUANG WAN is treatment kidney yin loss disease basis side commonly used, is the main prescription of nourishing kidney yin, to occurring the card of damage of kidney-YIN in the multiple chronic disease process, better curative effect is arranged all.But, according to clinical practice, performance deficiency of both QI and YIN patient is outstanding more to be seen, should also turn round and look at by gas the moon in the treatment, because LIUWEI DIHUANG WAN has only the merit of nourishing kidney yin, to deficiency of both QI and YIN patient unsatisfactory curative effect, therefore, be necessary the prescription of original LIUWEI DIHUANG WAN is improved, make it on the basis that deficiency of the kidney yin is had significant curative effect, can also to turn round and look at by gas the moon, help treatment the deficiency of both QI and YIN patient.
Summary of the invention
The object of the present invention is to provide a kind of Chinese medicine for the treatment of deficiency of the liver and kindey, deficiency of qi and yin, make it to have nourishing the liver and kidney, the effect of supplementing QI and nourishing YIN.
Another object of the present invention provides the preparation method of Chinese medicine of this treatment deficiency of the liver and kindey, deficiency of qi and yin.
Solution of the present invention is based on motherland's medical science to pathogenetic understanding of nephropathy and Therapeutic Principle, achieve with reference to modern pharmacological research, on the basis of the prescription raw material of the LIUWEI DIHUANG WAN that Radix Rehmanniae Preparata, Fructus Corni, Rhizoma Dioscoreae, Cortex Moutan, Rhizoma Alismatis, Poria are formed, increased Radix Panacis Quinquefolii, get the property that its sweetness and bitterness is slightly cold, formed a kind of new treatment deficiency of the liver and kindey, the root of American ginseng and rehmannia root medicine of deficiency of qi and yin card, boosting qi and nourishing yin is to control the card that deficiency of vital energy the moon loses.
Chinese medicine of the present invention is made by following component: (consumption is a weight portion)
Radix Panacis Quinquefolii 30～100, Radix Rehmanniae Preparata 80～230, Fructus Corni 40～130,
Rhizoma Dioscoreae 40～130, Cortex Moutan 30～100, Rhizoma Alismatis 30～100,
Poria 30～100.
Formula optimization weight (part) ratio range of preparation Chinese medicine of the present invention is:
Radix Panacis Quinquefolii 50～80, Radix Rehmanniae Preparata 120～190, Fructus Corni 60～110,
Rhizoma Dioscoreae 60～110, Cortex Moutan 40～80, Rhizoma Alismatis 50～80,
Poria 50～80.
The optimum weight of Chinese medicine of the present invention (part) proportioning is:
Radix Panacis Quinquefolii 60, Radix Rehmanniae Preparata 160, Fructus Corni 80,
Rhizoma Dioscoreae 80, Cortex Moutan 60, Rhizoma Alismatis 60,
Poria 60.
The Chinese medicine of treatment deficiency of the liver and kindey of the present invention, deficiency of qi and yin, it can be prepared into said dosage form on any pharmaceutics, and preferred for preparation is concentrated pill, tablet, capsule or oral liquid.
A kind of method for preparing the Chinese medicine of above-mentioned treatment deficiency of the liver and kindey, deficiency of qi and yin, it has following processing step:
(1) respectively distinguish the flavor of medical material extraction, concentrate:
A. Cortex Moutan:
I: Cortex Moutan is extracted with steam distillation, with distillate cold preservation, separate out crystallization, filter, the crystallization vacuum drying is also pulverized, and gets the paeonol crystal powder, and is standby, perhaps
II: Cortex Moutan is ground into fine powder, sieves, standby;
B. Radix Panacis Quinquefolii: get Cortex Moutan and be ground into fine powder, sieve, standby;
C. Fructus Corni, Poria, Rhizoma Dioscoreae:
I: decoct with water, filter, adopt the concentrating under reduced pressure method to be condensed into cream, perhaps
II: be ground into fine powder, sieve, standby;
C. Fructus Corni, Poria, Rhizoma Dioscoreae:
I: decoct with water, filter, adopt the concentrating under reduced pressure method to be condensed into cream, perhaps
II: be ground into fine powder, sieve, standby, perhaps
III: 14～45 parts (weight portions) getting in the Fructus Corni total amount decoct with water, and remainder is ground into fine powder, sieves, and is standby;
D. Radix Rehmanniae, Rhizoma Alismatis: decoct with water, filter, adopt the concentrating under reduced pressure method to be condensed into cream.
(2), adopt conventional method to make required dosage form with above-mentioned ointment, fine powder or crystal powder mixing.
The ointment of above-mentioned mixing, fine powder or crystal powder can adopt following technology to make required dosage form:
(1) adopt routine to mould the method for making pill, drying, polishing makes concentrated pill; Perhaps
(2) make granule through one-step-granulating method, compacting is made tablet in flakes then; Perhaps
(3) make granule through one-step-granulating method, filled capsules is made capsule then.
The method of the Chinese medicine of preparation treatment deficiency of the liver and kindey of the present invention, deficiency of qi and yin, wherein:
(1) during the Cortex Moutan steam distillation extracts, adds the water of 10～15 times (w/w);
(2) decoct with water in the medical material of respectively distinguishing the flavor of of extraction, add the water of 7～9 times (w/w), decoct 1～3 time, each 1～3h, collecting decoction filters concentrated then.
A kind of method for preparing the Chinese medicine of above-mentioned treatment deficiency of the liver and kindey, deficiency of qi and yin, the dosage form of described Chinese medicine is an oral liquid, it has following processing step:
A. get Cortex Moutan and add water, extract with steam distillation, collect distillate, medicinal residues are used in addition;
B. Cortex Moutan medicinal residues and Radix Panacis Quinquefolii, Radix Rehmanniae Preparata, Fructus Corni, Rhizoma Dioscoreae, the Rhizoma Alismatis that will obtain above extracted with decocting, filters, and filtrate and Cortex Moutan decocting liquid merge, and at pressure 0.6～0.9MPa concentrating under reduced pressure, put cold; Add ethanol and make and contain the alcohol amount and reach 58～75%, stir evenly, leave standstill 36～48h, filter, reclaim ethanol, filtrate for later use;
C. Poria decocts with water, and filters, and concentrates, and is standby;
D. with A, B, C gained medicinal liquid mixing, adding distil water to 1000 part (w/v) stirs evenly, filter, and embedding, high pressure steam sterilization makes the oral liquid of Chinese medicine of the present invention.
The method of the Chinese medicine of the above-mentioned treatment deficiency of the liver and kindey of preparation of the present invention, deficiency of qi and yin, the dosage form of described Chinese medicine is an oral liquid, wherein:
(1) during the Cortex Moutan steam distillation extracts, adds the water of 10～15 times (w/w);
(2) number of times that decocting extracts among the step B is 1～3 time, each 1.2～2.5h, and collecting decoction filters concentrated then;
(3) add 6～8 times of (w/w) water among the step C, decoct 1～3 time, each 1.2～2.5h, collecting decoction filters concentrated then.
Adopt the Test on Traditional Chinese Medicine index of treatment deficiency of the liver and kindey, deficiency of qi and yin of this method preparation as follows:
Thin layer is differentiated: 1, Fructus Corni should detect ursolic acid
2, Cortex Moutan should detect paeonol
Assay: 1, contain Cortex Moutan by paeonol (C
9H
10O
3) meter, must not be less than 2.0mg/g
2, contain Fructus Corni by ursolic acid (C
30H
48O
3) meter, must not be less than 0.3mg/g
3, contain Radix Panacis Quinquefolii with ginsenoside R
B1Meter must not be less than 1.5mg/g
Microbiological examination: antibacterial :≤30000/g
Mycete :≤100/g
Escherichia coli: must not detect
The important feature of the root of American ginseng and rehmannia root Chinese medicine of treatment treatment deficiency of the liver and kindey of the present invention, deficiency of qi and yin is: it has nourishing the liver and kidney, and the merit of supplementing QI and nourishing YIN cures mainly deficiency of the liver and kindey, the deficiency of qi and yin card.Disease is seen vertigo and tinnitus, fatigue and weakness, few speech of breathing hard, soreness of the waist and knees, the seminal emission dream is let out, hectic fever night sweat, feverish sensation in the palms and soles is quenched one's thirst, dry mouth and throat, dribbling urination or can't help, teeth shake, heel is had a pain, red tongue or light red, tongue is few, thready pulse or count duke or princess under an emperor accurately.The root of American ginseng and rehmannia root Chinese medicine of treatment deficiency of the liver and kindey of the present invention, deficiency of qi and yin is in the disease of the above-mentioned syndrome of performance, such as all using in the diseases such as chronic nephritis, leukopenia.
The specific embodiment
Embodiment 1: the present invention treats the clinical efficacy of deficiency of the liver and kindey, deficiency of qi and yin Chinese medicine
Be the therapeutic effect of checking Chinese medicine of the present invention to deficiency of the liver and kindey, deficiency of qi and yin disease, we adopt the embodiment of the invention 2 described concentrated watered pill preparations, (50 examples are treated to 80 examples in the first clinical hospital of Nanjing University of Traditional Chinese Medicine, 30 example contrasts) the chronic glomerulonephritis patient carries out clinical control and observes, and concrete clinical observation material is:
One, case choice criteria
(1) diagnostic criteria
1. Western medicine diagnose standard
With reference to the CHINESE JOURNAL OF INTERNAL MEDICINE editorial board nephropathy special interest group standard that peace meeting in Anhui is drafted in June, 1992.
| 1 | Onset is slow, state of an illness delay.Along with PD, can have that renal function goes down, anemia, situations such as electrolyte disturbance occur. |
| 2 | A kind of in the performance such as edema, hypertension, albuminuria, hematuria and cylinderuria or several can be arranged. |
| 3 | In the course of disease nephritis acute attack can be arranged. |
2. the dialectical standard of traditional Chinese medical science syndrome of deficiency of both qi and yin
With reference to second national traditional Chinese medical science nephropathy Symposium (Nanjing meeting) " the chronic primary glomerulopathy Chinese medical discrimination typing tentative program " that pass through in 1986 and the pattern of syndrome standard drafted of the 12 national traditional Chinese medical science nephropathy academic discussion (Wuxi meeting) in 1996.
| Main symptom | Lusterless complexion; Weak breath is weak, or easy catching a cold; Afternoon low grade fever, or feverish sensation in the palms and soles; Lumbago or edema. |
| Inferior card | Dry mouth and throat or pharyngeal dim red, pharyngalgia; Tongue is red partially or red partially, few tongue, thready pulse or a little less than |
3. Clinical typing standard
With reference to the academic meeting of second national nephropathy " suggestion of renal glomerular disease Clinical typing " the chronic nephritis diagnostic criteria of being revised in 1985.
| Plain edition | The various symptoms of nephritis are arranged, but do not have outstanding behaviours |
| The hypertension type | Except that general nephritis symptom, hypertensive outstanding behaviours is arranged |
| The acute attack type | The acute nephritic syndrome performance appears in chronic process |
4. state of an illness weight grade scale
With reference to the CHINESE JOURNAL OF INTERNAL MEDICINE editorial board nephropathy special interest group standard that peace meeting in Anhui is drafted in June, 1992.The weight of the state of an illness is mainly judged with aspects such as albuminuria, renal function, edema, hypertension, syndrome of blood stasis.All possess following any one can determine.
| Severe | The a urine protein continues ++～+++, very then continue to occur +++, or the 24h urine protein quantitation is between 2.1～3g, serum albumin＞30g/L; B renal function undesired (Cr 〉=133～442 μ mol/L); Obvious edema of c and hypertension; D has the performance of obvious syndrome of blood stasis: 1. darkish complexion or dark and gloomy; 2. lumbago is fixed or is twinge, squamous and dry skin or numb limbs and tense tendons; 3. colour of the tongue is purple dim or petechia, ecchymosis arranged; 4. pulse condition is carefully puckery; 5. urine fibrous protein catabolite (FDP) content raises; 6. hemorheology detects whole blood viscosity, plasma viscosity raises.All possess above 2 showers and can determine syndrome of blood stasis. |
| Moderate | The a urine protein continues ++, or the lasting 1～2g of 24h urine protein quantitation, renal function is normal; The b edema can gently can weigh, and hypertension can be arranged; C has the clinical manifestation of syndrome of blood stasis, and all possess above-mentioned 1 syndrome of blood stasis shower and can determine. |
| Slightly | The a urine protein continues ±～++, or the 24h urine protein quantitation continues below 1g, and renal function is normal; Not obvious or the nothing of b edema, blood pressure is normal; C has or does not have the syndrome of blood stasis clinical manifestation. |
(2) test case standard
1. case is included standard in
(1) at 18～60 years old age, the men and women does not limit.(2) meet the chronic glomerulonephritis diagnostic criteria.(3) Chinese medical discrimination belongs to syndrome of deficiency of both qi and yin, can have the wet or blood stasis standard card of water concurrently.(4) outpatient service of can follow up a case by regular visits to closely, observing or inpatient.
2. get rid of the case standard
| (1) chronic glomerulonephritis acute attack stage or be the patient of main symptom to mark real. | (2) with the patient of renal failure |
| (3) allergic constitution reaches this medicine allergy sufferers | (4) trimester of pregnancy or women breast-feeding their children |
| (5) the compliance difference or the mental status experimenter that can not finish according to testing program. | (6) merge serious primary disease such as cardiovascular, liver, kidney and hemopoietic system, psychotic. |
Two, clinical data
80 routine patients are divided into two groups at random all from outpatient service or inpatient.Wherein 50 examples are organized in treatment, matched group 30 examples.
Physical data
1. typing
| The man | The woman | Age (on average) | The course of disease (on average) (year) | The state of an illness | |||
| Severe | Moderate | Slightly | |||||
| Treatment group (example) | 29 | 21 | 34.2±13.7 | 2.9±1.7 | 16 | 26 | 8 |
| Matched group (example) | 16 | 14 | 36.8±14.4 | 2.6±2.3 | 9 | 16 | 5 |
Treatment is organized in 50 examples, plain edition 38 examples, hypertension type 12 examples.In matched group 30 examples, plain edition 23 examples, hypertension type 7 examples.
2. shape sign distribution situation
| Weak breath is weak | Lusterless complexion | Easy catching a cold | Feverish sensation in the palms and soles | Lumbago | Dry mouth and throat | Red partially, the few tongue of tongue | Thready pulse or a little less than | |
| Treatment group (example) | 50 | 31 | 26 | 24 | 21 | 20 | 42 | 38 |
| Matched group (just) | 29 | 20 | 19 | 16 | 13 | 11 | 27 | 23 |
More than two groups of case ordinary circumstances learn by statistics and handle there was no significant difference (P＞0.05) and have comparability.
Three, test method
1. medication:
The treatment group is given the concentrated pill of the embodiment of the invention 2, and is each 8,3 times/d, oral.Give persantin 25mg simultaneously, 3 times/d.
Matched group gives SHENYAN SIWEI PIAN (production of Shashi, Hubei pharmaceutical factory), and is each 8,3 times/d, oral.Be used persantin simultaneously, usage and dosage is with the treatment group.
More than two groups of patient's accompanied with hypertension persons all give the blood pressure lowering of converting enzyme inhibitor captopril.
2. course of treatment: 8 weeks were 1 course of treatment.
3. observe and require: all standard cases of including in that meets are the object of observation, by observing case history and observing form and fill in symptom and sign and relevant every check result.
4. test item: all defecate before and after the cases experiment, urine, routine blood test detects.24h urine protein quantitation, electrocardiogram, liver function (TBIL, ALT), renal function (BUN, Cr) were checked before treatment, the every 15d in treatment back checked once.
Four, criterion of therapeutical effect
1. curative effect of disease criterion
With reference to Ministry of Public Health " the clinical research guideline of new Chinese medicine treatment chronic nephritis " standard.
| Alleviate fully | Symptom and sign complete obiterations such as edema, continuous 3 urine protein examinations feminine gender or " ± " are more than 2 months, or the 24h urine protein quantitation continues less than 0.2g, urine erythrocyte disappears under the high power lens, the Urine sediments analyzer counting is normal, and renal function is normal. |
| The basic alleviation | Sings and symptomses such as edema disappear substantially; the urine protein continuous decrease is more than 50%; urine erythrocyte is no more than 3 under the high power lens; Urine sediments analyzer counting is near normal, and renal function is normal (being no more than 15% with normal value) normally or substantially. |
| Effectively | Symptoms such as edema and sign are clearly better; urine protein examination reduces "+" number; or between the 24h urine protein quantitation continuous decrease 25%～49%; urine erythrocyte is no more than 5 under the high power lens, and renal function is normal or make moderate progress. |
| Invalid | Clinical manifestation and above-mentioned lab testing all do not have obvious improvement or the anti-person of increasing the weight of. |
(2) symptom curative effect determinate standard
| Clinical recovery | The clinical symptoms of gas yin deficiency syndrome, sign disappear, and the syndrome integration reduces 〉=95%. |
| Produce effects | Clinical symptoms, the sign of gas yin deficiency syndrome are obviously improved, and the syndrome integration reduces 〉=70%. |
| Effectively | Clinical symptoms, the sign of gas yin deficiency syndrome all take a favorable turn, and the syndrome integration reduces 〉=30%. |
| Invalid | The clinical symptoms of gas yin deficiency syndrome, sign all do not have obvious improvement, even increase the weight of, the syndrome integration reduces less than 30%. |
Annotate: computing formula (nimodipine method) is [integration before (integration before the treatment-treatment back integration) ÷ treatment] * 100%.
Five, therapeutic outcome
(1) curative effect statistics
1. total effects relatively
| Alleviate fully | The basic alleviation | Effectively | Invalid | Total remission rate | Total effective rate | |
| Treatment group (example) | 22 | 13 | 9 | 6 | 70％ | 88％ |
| Matched group (example) | 7 | 9 | 6 | 8 | 53％ | 73％ |
Comparing total effective rate and total remission rate statistical analysis for two groups has significant difference (P＜0.05=illustrates that treatment group curative effect is better than matched group.
2. the component type curative effect relatively
| Plain edition (38 example) | Hypertension type (12 example) | |||||||||||
| Alleviate fully | The basic alleviation | Effectively | Invalid | Remission rate | Effective percentage | Alleviate fully | The basic alleviation | Effectively | Invalid | Remission rate | Effective percentage | |
| Treatment group (example) | 18 | 10 | 7 | 3 | 74％ | 92％ | 4 | 3 | 2 | 3 | 58％ | 75％ |
| Matched group (example) | 5 | 7 | 5 | 6 | 52％ | 74％ | 2 | 2 | 1 | 2 | 57％ | 71％ |
Two groups of plain editions are compared total remission rate, total effective rate to be had significant difference (P＜0.05, treatment group curative effect is better than matched group.The hypertension type is compared total remission rate, total effective rate there was no significant difference (P＞0.05) for two groups.
Compare between treatment group amphitypy, total effective rate, total remission rate all have significant difference (P＜0.05), illustrate that the root of American ginseng and rehmannia root ball is higher than the hypertension type to plain edition nephritis curative effect.Compare between the matched group amphitypy, total effective rate, total remission rate there are no significant difference (P＞0.05) illustrate that to contrast medicine similar to amphitypy nephritis curative effect.
The symptom and sign curative effect relatively
| Cure | Produce effects | Effectively | Invalid | Total effective rate | |
| Treatment group (example) | 10 | 15 | 19 | 6 | 88％ |
| Matched group (example) | 3 | 6 | 8 | 13 | 56.67％ |
Two groups of total effective rates are compared, and significant difference (P＜0.05) is arranged, and illustrate that curative effect is better than matched group to the treatment group aspect the clinical symptoms sign improving.
(2) untoward reaction
Treatment group and matched group are not all found any obvious adverse reaction in the clinical observation process.Each is organized the patient and all does inspections such as blood, urine, stool for routine, electrocardiogram, liver function, renal function, respectively detects 1 time before and after the treatment, all in normal range.
By above-mentioned clinical observation, we find that Chinese medicine that the present invention treats deficiency of the liver and kindey, deficiency of qi and yin is 70% to total remission rate of chronic glomerulonephritis syndrome of deficiency of both qi and yin patient disease, and total effective rate is 88%.To the general type of chronic glomerulonephritis patient, remission rate is up to 74%, and effective percentage is 92%; To the hypertension type of chronic glomerulonephritis patient, remission rate is 58%, and effective percentage is 75%, all obviously is better than matched group.The Chinese medicine of also pointing out the present invention to treat deficiency of the liver and kindey, deficiency of qi and yin simultaneously is higher than the hypertension type to plain edition nephritis curative effect.Drug safety is observed and is shown that the present invention treats the Chinese medicine of deficiency of the liver and kindey, deficiency of qi and yin and do not see tangible toxicity, is worth clinical application.
Embodiment 2: the preparation method 1 of the Chinese medicine concentrated pill of treatment deficiency of the liver and kindey, deficiency of qi and yin
Take by weighing raw material (kilogram) by following proportioning:
Radix Panacis Quinquefolii 60, Radix Rehmanniae Preparata 160, Fructus Corni 80,
Rhizoma Dioscoreae 80, Cortex Moutan 60, Rhizoma Alismatis 60,
Poria 60.
Production method is as follows:
Earlier Cortex Moutan is added 10 times of (weight ratio) water, extract with steam distillation, it is standby to leave and take medicinal residues, and gained is contained the distillate cold preservation of paeonol, separates out crystallization, filters, and the crystallization vacuum drying is also pulverized, the paeonol crystal powder, standby;
Get in the above-mentioned raw materials 27 parts in 80 parts of Fructus Corni, add 7 times of water gagings with Cortex Moutan medicinal residues, Radix Rehmanniae Preparata, Poria, Rhizoma Alismatis and decoct 2 times, each 2.5h, collecting decoction filters, and adopts distillation under vacuum to be condensed into cream; Radix Panacis Quinquefolii, Rhizoma Dioscoreae and residue powder of Fructus Corni be broken into " fine powder of the listed standard of Chinese pharmacopoeia, that is, this fine powder can be all by No. 5 sieves (80 order), and contain and can sieve (100 order) by No. 6 and be no less than 95% powder, mixing afterwards sieves; With above-mentioned ointment, fine powder, paeonol crystal powder mixing, adopt routine to mould the method for making pill, drying, polishing promptly gets the Chinese medicine concentrated pill that the present invention treats deficiency of the liver and kindey, deficiency of qi and yin.Concentrated pill of the present invention can be used for oral, one time 8 ball, and per 8 balls are equivalent to crude drug in whole 3g.
Adopt the Chinese medicine concentrated pill test rating of treatment deficiency of the liver and kindey, deficiency of qi and yin of this method preparation as follows:
Thin layer is differentiated: 1, Fructus Corni detects ursolic acid
2, Cortex Moutan detects paeonol
Assay: 1, paeonol (C
9H
10O
3): 2.1mg/g
2, ursolic acid (C
30H
48O
3): 0.31mg/g
3, ginsenoside R
B1: 1.6mg/g
Microbiological examination: antibacterial: 20000/g
Mycete: 60/g
Escherichia coli: do not detect
Embodiment 3: the preparation method 2 of the Chinese medicine concentrated pill of treatment deficiency of the liver and kindey, deficiency of qi and yin
Take by weighing raw material (kilogram) by following proportioning:
Radix Panacis Quinquefolii 30, Radix Rehmanniae Preparata 80, Fructus Corni 40,
Rhizoma Dioscoreae 40, Cortex Moutan 30, Rhizoma Alismatis 30,
Poria 30.
Production method is as follows:
Earlier Cortex Moutan is added 12 times of (weight ratio) water, extract with steam distillation, leave and take medicinal residues and get the paeonol crystal powder according to the method for embodiment 2, standby;
Get in the above-mentioned raw materials 14 parts in 40 parts of Fructus Corni, add 8 times of decoctings with Cortex Moutan medicinal residues, Radix Rehmanniae Preparata, Poria, Rhizoma Alismatis and boil 2 times, each 2h, collecting decoction filters, and distilling under reduced pressure is condensed into cream;
Radix Panacis Quinquefolii, Rhizoma Dioscoreae and residue powder of Fructus Corni are broken into fine powder (standard is the same), sieve mixing;
With above-mentioned ointment, fine powder, paeonol crystal powder mixing, routine is moulded the method for making pill, drying, and polishing promptly gets the Chinese medicine concentrated pill that the present invention treats deficiency of the liver and kindey, deficiency of qi and yin.Concentrated pill of the present invention can be used for oral, one time 8 ball, and per 8 balls are equivalent to crude drug in whole 3g.
Adopt the Chinese medicine concentrated pill test rating of treatment deficiency of the liver and kindey, deficiency of qi and yin of this method preparation as follows:
Thin layer is differentiated: 1, Fructus Corni detects ursolic acid
2, Cortex Moutan detects paeonol
Assay: 1, paeonol (C
9H
10O
3): 2.18mg/g
2, ursolic acid (C
30H
48O
3): 0.33mg/g
3, ginsenoside R
B1: 1.56mg/g
Microbiological examination: antibacterial: 16000/g
Mycete: 40/g
Escherichia coli: do not detect
Embodiment 4: the preparation method 3 of the Chinese medicine concentrated pill of treatment deficiency of the liver and kindey, deficiency of qi and yin
Take by weighing raw material (kilogram) by following proportioning:
Radix Panacis Quinquefolii 100, Radix Rehmanniae Preparata 230, Fructus Corni 130,
Rhizoma Dioscoreae 130, Cortex Moutan 100, Rhizoma Alismatis 100,
Poria 100.
Production method is as follows:
Earlier Cortex Moutan is added 15 times of (weight ratio) water, extract with steam distillation, leave and take medicinal residues and get the paeonol crystal powder according to the method for embodiment 2, standby;
Get in the above-mentioned raw materials 45 parts in 130 parts of Fructus Corni, add 9 times of decoctings with Cortex Moutan medicinal residues, Radix Rehmanniae Preparata, Poria, Rhizoma Alismatis and boil 2 times, each 1.5h, collecting decoction filters, and distilling under reduced pressure is condensed into cream;
Radix Panacis Quinquefolii, Rhizoma Dioscoreae and residue powder of Fructus Corni are broken into fine powder (standard is the same), sieve mixing; With above-mentioned ointment, fine powder, paeonol crystal powder mixing, routine is moulded the method for making pill, drying, and polishing promptly gets the Chinese medicine concentrated pill that the present invention treats deficiency of the liver and kindey, deficiency of qi and yin.Concentrated pill of the present invention can be used for oral, one time 8 ball, and per 8 balls are equivalent to crude drug in whole 3g.
Adopt the Chinese medicine concentrated pill test rating of treatment deficiency of the liver and kindey, deficiency of qi and yin of this method preparation as follows:
Thin layer is differentiated: 1, Fructus Corni detects ursolic acid
2, Cortex Moutan detects paeonol
Assay: 1, paeonol (C
9H
10O
3): 2.3mg/g
2, ursolic acid (C
30H
48O
3): 0.35mg/g
3, ginsenoside R
B1: 1.65mg/g
Microbiological examination: antibacterial: 15000/g
Mycete: 50/g
Escherichia coli: do not detect
Embodiment 5: the preparation method of the Chinese medicinal tablet of treatment deficiency of the liver and kindey, deficiency of qi and yin
Take by weighing raw material (kilogram) by following proportioning:
Radix Panacis Quinquefolii 50, Radix Rehmanniae Preparata 120, Fructus Corni 60,
Rhizoma Dioscoreae 60, Cortex Moutan 40, Rhizoma Alismatis 50,
Poria 50.
Production method is as follows:
Get Radix Panacis Quinquefolii, Cortex Moutan, Fructus Corni, Poria powder and be broken into fine powder (standard is the same), sieve, mixing, residue three flavor raw material Radix Rehmanniae Preparata, Rhizoma Dioscoreae, Rhizoma Alismatis decoct with water three times, each 2h of first and second time, 1h for the third time, collecting decoction filters, and is condensed into cream; Ointment and fine powder are made granule through one-step-granulating method, and compacting in flakes.Oral, one time 8, every 0.4g.
Embodiment 6: the preparation method of the Chinese medicinal capsule agent of treatment deficiency of the liver and kindey, deficiency of qi and yin
Take by weighing raw material (kilogram) by following proportioning:
Radix Panacis Quinquefolii 60, Radix Rehmanniae Preparata 120, Fructus Corni 60,
Rhizoma Dioscoreae 60, Cortex Moutan 40, Rhizoma Alismatis 50,
Poria 50.
Production method is as follows:
Get Radix Panacis Quinquefolii, Cortex Moutan, Fructus Corni, Poria powder and be broken into fine powder (standard is the same), sieve, mixing, residue three flavor raw material Radix Rehmanniae Preparata, Rhizoma Dioscoreae, Rhizoma Alismatis decoct with water three times, each 2h of first and second time, 1h for the third time, collecting decoction filters, and is condensed into cream; Ointment and fine powder are made granule through one-step-granulating method, fill No. 1 capsule, oral, one time 8, every 0.35g.
Embodiment 7: the extract oral liquid and preparation method thereof 1 of treatment deficiency of the liver and kindey, deficiency of qi and yin
Take by weighing raw material (kilogram) by following proportioning:
Radix Panacis Quinquefolii 80, Radix Rehmanniae Preparata 190, Fructus Corni 110,
Rhizoma Dioscoreae 110, Cortex Moutan 80, Rhizoma Alismatis 80,
Poria 80.
Production method is as follows:
Get Cortex Moutan and add 10 times of (w/w) water, extract with steam distillation, collect distillate, medicinal residues are used in addition;
The Cortex Moutan medicinal residues and Radix Panacis Quinquefolii, Radix Rehmanniae Preparata, Fructus Corni, Rhizoma Dioscoreae, the Rhizoma Alismatis that obtain are above extracted with decocting, and the number of times of extraction is 2 times, each 2h, and collecting decoction filters, and filtrate and Cortex Moutan decocting liquid merge, and at pressure 0.6MPa concentrating under reduced pressure, put cold; Add ethanol and make and contain the alcohol amount and reach 58%, stir evenly, leave standstill 36h, filter, reclaim ethanol, filtrate for later use.
Poria adds 6 times of water gagings and decocts 2 times, each 2.5h, and collecting decoction filters, and concentrates, and is standby.
E. with above-mentioned gained medicinal liquid mixing, adding distil water to 1000 part stirs evenly, filter, and embedding, high pressure steam sterilization promptly gets the Chinese medicine oral liquid of treatment deficiency of the liver and kindey of the present invention, deficiency of qi and yin.
Embodiment 8: the extract oral liquid and preparation method thereof 2 of treatment deficiency of the liver and kindey, deficiency of qi and yin
Take by weighing raw material (kilogram) by following proportioning:
Radix Panacis Quinquefolii 80, Radix Rehmanniae Preparata 160, Fructus Corni 80,
Rhizoma Dioscoreae 80, Cortex Moutan 60, Rhizoma Alismatis 60,
Poria 60.
Production method is as follows:
Get Cortex Moutan and add 15 times of (w/w) water, extract with steam distillation, collect distillate, medicinal residues are used in addition;
The Cortex Moutan medicinal residues and Radix Panacis Quinquefolii, Radix Rehmanniae Preparata, Fructus Corni, Rhizoma Dioscoreae, the Rhizoma Alismatis that obtain are above extracted with decocting, and the number of times of extraction is 2 times, each 1.5h, and collecting decoction filters, and filtrate and Cortex Moutan decocting liquid merge, and at pressure 0.9MPa concentrating under reduced pressure, put cold; Add ethanol and make and contain the alcohol amount and reach 70%, stir evenly, leave standstill 42h, filter, reclaim ethanol, filtrate for later use.
Poria adds 8 times of water gagings and decocts 2 times, each 2h, and collecting decoction filters, and concentrates, and is standby.
With above-mentioned gained medicinal liquid mixing, adding distil water to 1000 part stirs evenly, filter, and embedding, high pressure steam sterilization promptly gets the Chinese medicine oral liquid of treatment deficiency of the liver and kindey of the present invention, deficiency of qi and yin.
Claims (13)
1. Chinese medicine for the treatment of deficiency of the liver and kindey, deficiency of qi and yin is characterized in that it is the medicament of being made by the following weight proportion raw material:
Radix Panacis Quinquefolii 60, Radix Rehmanniae Preparata 160, Fructus Corni 80,
Rhizoma Dioscoreae 80, Cortex Moutan 60, Rhizoma Alismatis 60,
Poria 60.
2. Chinese medicine for the treatment of deficiency of the liver and kindey, deficiency of qi and yin is characterized in that it is the medicament of being made by the following weight proportion raw material:
Radix Panacis Quinquefolii 100, Radix Rehmanniae Preparata 230, Fructus Corni 130,
Rhizoma Dioscoreae 130, Cortex Moutan 100, Rhizoma Alismatis 100,
Poria 100.
3. Chinese medicine for the treatment of deficiency of the liver and kindey, deficiency of qi and yin is characterized in that it is the medicament of being made by the following weight proportion raw material:
Radix Panacis Quinquefolii 50, Radix Rehmanniae Preparata 120, Fructus Corni 60,
Rhizoma Dioscoreae 60, Cortex Moutan 40, Rhizoma Alismatis 50,
Poria 50.
4. Chinese medicine for the treatment of deficiency of the liver and kindey, deficiency of qi and yin is characterized in that it is the medicament of being made by the following weight proportion raw material:
Radix Panacis Quinquefolii 60, Radix Rehmanniae Preparata 120, Fructus Corni 60,
Rhizoma Dioscoreae 60, Cortex Moutan 40, Rhizoma Alismatis 50,
Poria 50.
5. Chinese medicine for the treatment of deficiency of the liver and kindey, deficiency of qi and yin is characterized in that it is the medicament of being made by the following weight proportion raw material:
Radix Panacis Quinquefolii 80, Radix Rehmanniae Preparata 190, Fructus Corni 110,
Rhizoma Dioscoreae 110, Cortex Moutan 80, Rhizoma Alismatis 80,
Poria 80.
6. Chinese medicine for the treatment of deficiency of the liver and kindey, deficiency of qi and yin is characterized in that it is the medicament of being made by the following weight proportion raw material:
Radix Panacis Quinquefolii 80, Radix Rehmanniae Preparata 160, Fructus Corni 80,
Rhizoma Dioscoreae 80, Cortex Moutan 60, Rhizoma Alismatis 60,
Poria 60.
7. according to the Chinese medicine of any described treatment deficiency of the liver and kindey of claim 1～6, deficiency of qi and yin, it is characterized in that said medicament is a said dosage form on any pharmaceutics.
8. the Chinese medicine of treatment deficiency of the liver and kindey according to claim 7, deficiency of qi and yin is characterized in that said medicament is concentrated pill, tablet, capsule or oral liquid.
9. method for preparing the Chinese medicine of any described treatment deficiency of the liver and kindey of claim 1～6, deficiency of qi and yin is characterized in that having following processing step:
(1) respectively distinguish the flavor of medical material extraction, concentrate:
A. Cortex Moutan:
I: Cortex Moutan is extracted with steam distillation, with distillate cold preservation, separate out crystallization, filter, the crystallization vacuum drying is also pulverized, and gets Cortex Moutan phenol crystal powder, and is standby, perhaps
II: Cortex Moutan is ground into fine powder, sieves, standby;
B. Radix Panacis Quinquefolii: get Radix Panacis Quinquefolii powder and be broken into fine powder, sieve, standby;
C. Fructus Corni, Poria, Rhizoma Dioscoreae:
I: decoct with water, filter, adopt the concentrating under reduced pressure method to be condensed into cream, perhaps
II: be ground into fine powder, sieve, standby, perhaps
III: 14～45 parts (weight portion) and the Poria got in the Fructus Corni total amount decoct with water, and filter, and adopt the concentrating under reduced pressure method to be condensed into cream, and residue Fructus Corni part and Rhizoma Dioscoreae are ground into fine powder together, sieve, and be standby;
D. Radix Rehmanniae Preparata, Rhizoma Alismatis: decoct with water, filter, adopt the concentrating under reduced pressure method to be condensed into cream;
(2), adopt conventional method to make required dosage form with above-mentioned ointment, fine powder or crystal powder mixing.
10. method as claimed in claim 9 is characterized in that ointment, fine powder or the crystal powder of above-mentioned mixing can adopt following technology to make required dosage form:
(1) adopt routine to mould the method for making pill, drying, polishing makes concentrated pill; Perhaps
(2) make granule through one-step-granulating method, compacting is made tablet in flakes then; Perhaps
(3) make granule through one-step-granulating method, filled capsules is made capsule then.
11., it is characterized in that as claim 9 or 10 described methods:
(1) during the Cortex Moutan steam distillation extracts, adds the water of 10～15 times (w/w);
(2) decoct with water in the medical material of respectively distinguishing the flavor of of extraction, add the water of 7～9 times (w/w), decoct 1～3 time, each 1～3 hour, collecting decoction filtered concentrated then.
12. a method for preparing the Chinese medicine of any described treatment deficiency of the liver and kindey of claim 1～6, deficiency of qi and yin, the dosage form of described Chinese medicine is an oral liquid, it is characterized in that having following processing step:
A. get Cortex Moutan and add water, extract with steam distillation, collect distillate, medicinal residues are used in addition;
B. Cortex Moutan medicinal residues and Radix Panacis Quinquefolii, Radix Rehmanniae Preparata, Fructus Corni, Rhizoma Dioscoreae, the Rhizoma Alismatis that will obtain above extracted with decocting, filters, and filtrate and Cortex Moutan decocting liquid merge, and are 0.6～0.9MPa concentrating under reduced pressure in vacuum, put cold; Add ethanol and make and contain the alcohol amount and reach 58～75%, stir evenly, left standstill 36～48 hours, filter, reclaim ethanol, filtrate for later use;
C. Poria decocts with water, and filters, and concentrates, and is standby;
D. with A, B, C gained medicinal liquid mixing, adding distil water to 1000 part (w/v) stirs evenly, and filters embedding, last high pressure steam sterilization.
13. method as claimed in claim 12 is characterized in that:
(1) during the Cortex Moutan steam distillation extracts, adds the water of 10～15 times (w/w);
(2) number of times that decocting extracts among the step B is 1～3 time, and each 1.2～2.5 hours, collecting decoction filtered concentrated then;
(3) add 6～8 times of (w/w) water among the step C, decoct 1～3 time, each 1.2～2.5 hours, collecting decoction filtered concentrated then.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 03106361 CN1222305C (en) | 2003-02-25 | 2003-02-25 | Chinese medicine for treating liver-kidney insufficiency, qi and yin vacuity and its preparation method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 03106361 CN1222305C (en) | 2003-02-25 | 2003-02-25 | Chinese medicine for treating liver-kidney insufficiency, qi and yin vacuity and its preparation method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1442164A CN1442164A (en) | 2003-09-17 |
| CN1222305C true CN1222305C (en) | 2005-10-12 |
Family
ID=27796636
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 03106361 Expired - Lifetime CN1222305C (en) | 2003-02-25 | 2003-02-25 | Chinese medicine for treating liver-kidney insufficiency, qi and yin vacuity and its preparation method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1222305C (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1981845B (en) * | 2005-12-15 | 2011-04-20 | 河南省宛西制药股份有限公司 | Chinese-medicinal composition, its production and use |
| CN102552628A (en) * | 2012-01-09 | 2012-07-11 | 李承平 | Pharmaceutical composition for nourishing yin and tonifying kidney |
| CN102846907A (en) * | 2012-09-12 | 2013-01-02 | 李承平 | Tortoise-plastron glue kidney tonifying tablet |
| CN104644965A (en) * | 2015-01-26 | 2015-05-27 | 四川宜健生物科技有限公司 | Traditional Chinese medicine composition for replenishing qi and blood and preparation method thereof |
-
2003
- 2003-02-25 CN CN 03106361 patent/CN1222305C/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| CN1442164A (en) | 2003-09-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1457829A (en) | Chinese medicine composition for curing chronic atrophic sastritis and its preparing method and quality control method | |
| CN1209128C (en) | Traditional Chinese medicine composition with function of treating dysmenorrhea and beautifying | |
| CN1840001A (en) | Method for preparing mixture with pubescent angelica root and loranthus | |
| CN1565552A (en) | Chinese traditional medicine for treating immune hypofunction and disfunction | |
| CN1239183C (en) | A pharmaceutical composition made from Chinese traditional medicine and preparation method thereof | |
| CN1742876A (en) | Chinese medicine for treating tractures and preparation for making plaster thereof | |
| CN1698878A (en) | Kidney replenishing medicinal composition and its preparation process and novel use | |
| CN1212134C (en) | Compound Chinese medicine prepn for treating urinary system infection and prostatitis and its prepn process | |
| CN100346817C (en) | Chinese medicine composition for preventing and treating hypertension, hyperlipemia and hyperglycemia | |
| CN1917895A (en) | Extracts of houttuynia cordata and rubus coreanus and their composition for preventing and treating allergic diseases | |
| CN1191082C (en) | Chinese medicinal composition for treating fatty liver and its preparation method | |
| CN1222305C (en) | Chinese medicine for treating liver-kidney insufficiency, qi and yin vacuity and its preparation method | |
| CN1323687C (en) | Blood supplementing iron supplementing medicineal preparation and its preparation method | |
| CN1245189C (en) | Composition for strengthening body resistance and restoring and function, strengthening spleen and kidney, relieving metal stress and promoting blood circulation to remove blood stasis | |
| CN1559495A (en) | Deer's fetus granular Chinese madicinal preparation and its production technology | |
| CN1221280C (en) | Chinese patent drug for treating heart brain blood vessel disease and its preparation method | |
| CN1899325A (en) | Granule for treating infant diarrhea | |
| CN1299734C (en) | Composition of traditional Chinese medicine for large intestine hygropyretic disease and its preparation method | |
| CN1290529C (en) | Medicine for treating gout, hyperuricemia and hyperlipemia and preparation method thereof | |
| CN1820770A (en) | Chinese medicine composition for treating apoplexy and its preparing method | |
| CN1548138A (en) | Chinese medicine composition for treating consumptive disease and its quality control method | |
| CN101057952A (en) | Medicinal composition for treating dysmenorrhoea and its preparation method and application | |
| CN1733089A (en) | Medicine for treating diabetes and its complications and process for preparing the same | |
| CN1742984A (en) | Medicine copmosition, its preparing method and quality control method | |
| CN1562113A (en) | Medicine for treating chronic pelvic inflammation and its preparing method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C56 | Change in the name or address of the patentee | ||
| CP03 | Change of name, title or address |
Address after: 474500 No. 168 Zhongjing Road, Xixia County, Henan Province Patentee after: ZHONGJING WANXI PHARMACEUTICAL Co.,Ltd. Address before: 473000, No. 221 irrigation Road, Xixia County, Nanyang, Henan Patentee before: Henan Wanxi Pharmaceutical Co.,Ltd. |
|
| CX01 | Expiry of patent term |
Granted publication date: 20051012 |
|
| CX01 | Expiry of patent term |